FDA Issues Warning About Risky Vein Opening Procedure
The Food and Drug Administration on Wednesday again warned patients and doctors to avoid a risky, experimental procedure promoted as a treatment for several nervous system disorders, including multiple sclerosis and Parkinson's disease.